Life Sciences Report Collection
The Life Sciences Collection spans markets that are central to the life and wellbeing of the more than 7.5 billion people on our planet. From emerging diagnostics, to brand new therapies and treatment technologies, our expert analysts know where your focus – and investment – should be when it comes to biotechnology, pharmaceuticals and healthcare. As your senior editor, I look forward to introducing you to new opportunities.
Global Markets for Catheters -- Focus on Asia
BCC Research’s goal in conducting this study was to determine the present status of the worldwide catheter market (with a focus on Asia) and to evaluate its potential over the five-year period from 2011 to 2016.
Global Markets for Devices for Treating Congestive Heart Failure ...
This report is a comprehensive business tool designed to provide an in-depth look at devices for the congestive heart failure market. The geographic scope of the report is global with a special emphasis on Emerging Markets. Includes forecasts through 2016.
Global Markets for Devices for Treating Congestive Heart Failure ...
This report is a comprehensive business tool designed to provide an in-depth look at devices for the congestive heart failure market. The geographic scope of the report is global with a special emphasis on the Americas. Includes forecasts through 2016.
Global Markets for Devices for Treating Congestive Heart Failure ...
This report is a comprehensive business tool designed to provide an in-depth look at devices for the congestive heart failure market. The geographic scope of the report is global with a special emphasis on Europe. Includes forecasts through 2016.
Global Markets for Devices for Treating Congestive Heart Failure ...
This report is a comprehensive business tool designed to provide an in-depth look at devices for the congestive heart failure market. The geographic scope of the report is global with a special emphasis on Asia. Includes forecasts through 2016.
Global Markets for Devices for Treating Congestive Heart Failure
The global market for congestive heart failure devices was $3.1 billion in 2010. This global market reached nearly $3.4 billion in 2011 and is expected to grow to $5.9 billion by 2016, a compound annual growth rate (CAGR) of 11.7%.
Global Markets and Technologies for Medical Lasers: Focus on Asia...
This report focuses on the asia-pacific and rest-of-world market for medical lasers. The overall goal of this study is to provide the reader with an up-to-date understanding of the technological, economic, and regulatory forces that are influencing the future size and structure of the market for medical lasers.
Global Markets and Technologies for Medical Lasers: Focus on the ...
This report focuses on US and canadian market. The overall goal of this study is to provide the reader with an up-to-date understanding of the technological, economic, and regulatory forces that are influencing the future size and structure of the market for medical lasers.
Global Markets and Technologies for Medical Lasers: Focus on Euro...
This report focuses on the European market for medical lasers. The overall goal of this study is to provide the reader with an up-to-date understanding of the technological, economic, and regulatory forces that are influencing the future size and structure of the market for medical lasers.
Labeling and Linkage Agents for Immunoassays and Gene Probes
The market for immunoagents, probes and molecular diagnostics was $29.6 billion in 2010. This market is projected to be $33.5 billion in 2011 and will increase up to $60.3 billion by 2016 at a compound annual growth rate (CAGR) of 12.5%.
Drugs and Treatments for Autoimmune Diseases: Global Markets
The global market for autoimmune treatments reached at $34 billion in 2010, it is expected to reach at $38.9 billion by 2011 and it will further grow to $55 billion by 2016 at a compounded annual growth rate (CAGR) of 7.2%.
Drugs for Treating Congestive Heart Failure: Global Markets
The global market for congestive heart failure pharmaceuticals was valued at nearly $11.2 billion in 2010. This market is expected to reach nearly $12.2 billion in 2011 and $18.6 billion in 2016, a compound annual growth rate (CAGR) of 8.9% between 2011 and 2016.
Global Markets for Marine-Derived Pharmaceuticals
The global market for marine-derived drugs by type was around $4.8 billion in 2011, which is expected to be around $5.3 billion in 2012. This global market is forecasted to reach $8.6 billion by 2016 at a compound annual growth rate (CAGR) of 12.5% for the five year period of 2011 to 2016.
Arthroscopy Products and Procedures: Global Markets
The global market for arthroscopic products is projected to reach nearly $4.6 billion by 2015, from nearly $3 billion in 2010, a compound annual growth rate of 9.1%. The largest gains will be in the shoulder, hip, and extremities product markets.
Medical Imaging Technologies for Oncology Diagnostics: The Global...
The global market for diagnostic imaging equipment for oncology reached more than $11.6 billion in 2010 and, despite the global recession, is forecast to grow to about $14.8 billion by 2015, an overall compound annual growth rate (CAGR) of 5% for 2010 through 2015.
Medical Enzymes: Technologies and Global Markets
The market for enzymes in medicine is growing. The global market for medical enzymes is estimated at $6 billion in 2010. The market is growing at a compound annual growth rate (CAGR) of 3.9%, to reach $7.2 billion in 2015.
Stem Cell Therapeutics for Oncology: Technologies and Global Mark...
The global stem cell anticancer therapeutics market was valued at $859 million in 2010. This market is expected to increase at an 11.3% compound annual growth rate (CAGR) to reach nearly $1.5 billion in 2015.
Markets for Emerging Pharmaceutical Technologies
As a segment, therapeutic vaccines recorded $19.3 billion in 2010, a figure that is expected to grow to $31.9 billion by 2015, demonstrating a compound annual growth rate (CAGR) of 10.6%.
Emerging Regional Markets for Therapeutic Drugs
The overall emerging markets for therapeutic drugs totaled $131.4 billion in 2009. These regions include Latin America, China, Eastern Europe, the Middle East, South Korea, India, Russia, and South Africa. These regions are estimated at $145.8 billion in 2010 and expected to continue aggressive growth through 2015, reaching a figure of $214.2 billion, yielding a compound annual growth rate (CAGR) of 8% from 2010 to 2015.
Therapeutics for Immune System Disorders
In 2010, the global market for drugs for the treatment of immune disease was estimated to be approximately $72.2 billion. The market size is forecast to grow at a compound annual growth rate (CAGR) of 2.6% to reach $82.2 billion by 2015.
The Clinical Trials Business
New technologies and the outsourcing of clinical trials to lower-cost countries will slow the recent annual increases in expenditures in the U.S. to a 3.3% compound annual growth rate (CAGR) over the forecast period. Clinical trial spending in 2010 is an estimated $25 billion and is expected to reach $28.5 billion by 2014.
Therapeutic Drugs for Central Nervous System (CNS) Disorders: Tec...
This study provides a comprehensive analysis of central nervous system therapies on a global basis. It provides a range of information, from detailed product analyses within disease sub-segments to overall industry trends, in order to quantify and qualify the market for therapeutic drug products in the central nervous system sector.
Oncology Adjuvants: Technologies and Global Markets
This report covers the current status of the global oncolytic adjuvant marketplace and assess its growth potential over the five-year period from 2010 to 2015
Therapeutics and Biomaterials for Musculoskeletal Disease: Global...
Determine the current status of the musculoskeletal disease (MSD) treatments and assess the growth potential of this area over a 5-year period from 2009 to 2014.
Cardiovascular Therapeutic Drugs: Technologies and Global Markets
This study provides a comprehensive analysis of cardiovascular therapies on a global basis. Its aim is to provide a range of information, from detailed product analyses within disease subsegments to overall industry trends, in order to quantify and qualify the market for therapeutic drug products in the cardiovascular segment. Includes forecasts through 2015
Nanotechnology in Cancer Treatment: Technologies and Global Markets
This report provides an overview of nanotechnology in cancer treatment and analyzes market trends.
Global Markets and Manufacturing Technologies for Protein Drugs
This report provides an overview of the global markets for protein drugs and drug manufacturing technologies.
Global Biochip Markets: Microarrays and Lab-on-a-Chip
This report provides an overview of the global biochip markets.
Global Microbiome Sequencing Market
This report provides an overview of the global market for microbiome sequencing.